| dc.contributor.author | Oyen, WJG | |
| dc.contributor.author | Jones, C | |
| dc.date.accessioned | 2017-12-19T14:57:46Z | |
| dc.date.issued | 2018-04-01 | |
| dc.identifier.citation | Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, 59 (4), pp. 610 - 611 | |
| dc.identifier.issn | 0161-5505 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/979 | |
| dc.identifier.eissn | 1535-5667 | |
| dc.identifier.doi | 10.2967/jnumed.117.200527 | |
| dc.format | Print-Electronic | |
| dc.format.extent | 610 - 611 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.publisher | SOC NUCLEAR MEDICINE INC | |
| dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| dc.subject | Pons | |
| dc.subject | Humans | |
| dc.subject | Glioma | |
| dc.subject | Astrocytoma | |
| dc.subject | Brain Stem Neoplasms | |
| dc.subject | Child | |
| dc.title | Immuno-PET in Pontine Glioma: More Than Meets the Eye? | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2017-11-27 | |
| rioxxterms.versionofrecord | 10.2967/jnumed.117.200527 | |
| rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| rioxxterms.licenseref.startdate | 2018-04 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | Journal of nuclear medicine : official publication, Society of Nuclear Medicine | |
| pubs.issue | 4 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Glioma Team | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Glioma Team | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Molecular Imaging | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Glioma Team | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Glioma Team | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Translational Molecular Imaging | |
| pubs.publication-status | Published | |
| pubs.volume | 59 | |
| pubs.embargo.terms | Not known | |
| icr.researchteam | Glioma Team | |
| icr.researchteam | Translational Molecular Imaging | |
| dc.contributor.icrauthor | Jones, Chris | |
